BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 25382223)

  • 1. Development of effective skin cancer treatment and prevention in xeroderma pigmentosum.
    Lambert WC; Lambert MW
    Photochem Photobiol; 2015; 91(2):475-83. PubMed ID: 25382223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xeroderma pigmentosum in the United kingdom.
    Lehmann AR
    Photochem Photobiol; 2015; 91(2):484-5. PubMed ID: 24943090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forty years of research on xeroderma pigmentosum at the US National Institutes of Health.
    Kraemer KH; DiGiovanna JJ
    Photochem Photobiol; 2015; 91(2):452-9. PubMed ID: 25220021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
    Magnaldo T; Sarasin A
    Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on 'xeroderma pigmentosum'.
    Fassihi H
    Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm.
    Kraemer KH; Lee MM; Andrews AD; Lambert WC
    Arch Dermatol; 1994 Aug; 130(8):1018-21. PubMed ID: 8053698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum.
    Cleaver JE
    J Dermatol Sci; 2000 May; 23(1):1-11. PubMed ID: 10699759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
    Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
    Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Xeroderma pigmentosum].
    Takeuchi S
    Nihon Rinsho; 2000 Jul; 58(7):1496-500. PubMed ID: 10921330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
    Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
    Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xeroderma pigmentosum clinical practice guidelines.
    Moriwaki S; Kanda F; Hayashi M; Yamashita D; Sakai Y; Nishigori C;
    J Dermatol; 2017 Oct; 44(10):1087-1096. PubMed ID: 28771907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Xeroderma pigmentosum (XP) : A genetic disease sheds light on UV-induced skin cancer].
    Emmert B; Hallier E; Schön MP; Emmert S
    Hautarzt; 2011 Feb; 62(2):91-7. PubMed ID: 21243329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
    Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
    Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene.
    Nakane H; Takeuchi S; Yuba S; Saijo M; Nakatsu Y; Murai H; Nakatsuru Y; Ishikawa T; Hirota S; Kitamura Y
    Nature; 1995 Sep; 377(6545):165-8. PubMed ID: 7675085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.
    Opletalova K; Bourillon A; Yang W; Pouvelle C; Armier J; Despras E; Ludovic M; Mateus C; Robert C; Kannouche P; Soufir N; Sarasin A
    Hum Mutat; 2014 Jan; 35(1):117-28. PubMed ID: 24130121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma and other skin cancers in xeroderma pigmentosum patients and mutation in their cells.
    Takebe H; Nishigori C; Tatsumi K
    J Invest Dermatol; 1989 May; 92(5 Suppl):236S-238S. PubMed ID: 2715657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
    Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
    Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discovery that xeroderma pigmentosum (XP) results from defective nucleotide excision repair.
    Friedberg EC
    DNA Repair (Amst); 2004 Feb; 3(2):183, 195. PubMed ID: 14706352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Xeroderma Pigmentosum in Japan: Lessons From Two Clinical Surveys and Measures for Patient Care.
    Nishigori C; Nakano E; Masaki T; Ono R; Takeuchi S; Tsujimoto M; Ueda T
    Photochem Photobiol; 2019 Jan; 95(1):140-153. PubMed ID: 30565713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic counseling and DNA testing in patients with increased risks for malignant melanoma].
    Itin PH; Fistarol SK
    Ther Umsch; 2003 Aug; 60(8):469-72. PubMed ID: 14502854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.